SCHEMBL30424432

SCHEMBL30424432

CNCc1nn(-c2ccc(OC(F)(F)F)cc2)c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 3/20 0.60
▸ TEAD4 Q15561 3/20 0.60
▸ TEAD2 Q15562 3/20 0.60
▸ TEAD3 Q99594 3/20 0.60
▸ PRMT1 Q99873 1/20 0.41
▸ PTGER4 P35408 2/20 0.41
▸ ABCB1 P08183 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ HTT P42858 1/20 0.39
▸ RARG P13631 1/20 0.38
▸ RORC P51449 1/20 0.38
▸ SCN9A Q15858 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ PLA2G1B P04054 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ATG4B Q9Y4P1 1/20 0.38
▸ GPR39 O43194 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25239105 1.00 TEAD1 (0.60) TEAD1TEAD4TEAD2TEAD3PRMT1
Hydrochloric Acid SCHEMBL25237493 0.99 TEAD1 (0.59) TEAD1TEAD4TEAD2TEAD3PRMT1
SCHEMBL25274345 0.85 TEAD1 (0.57) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL30469150 0.85 TEAD1 (0.57) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL25749012 0.85 TEAD1 (0.63) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL25232718 0.85 TEAD1 (0.61) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL25237292 0.84 TEAD1 (0.61) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL4792952 0.84 TEAD1 (0.63) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL4792411 0.84 TEAD1 (0.66) TEAD1TEAD4TEAD2TEAD3PTGER4
Hydrochloric Acid SCHEMBL25208896 0.84 TEAD1 (0.60) TEAD1TEAD4TEAD2TEAD3PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436957-A1 THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER Genentech, Inc. (US) 2024-10-02 — — EP disclosed
CN-118302411-A Therapeutic indazole compounds and methods of use thereof for the treatment of cancer 基因泰克公司 2024-07-05 — — CN disclosed
WO-2023097195-A1 THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER GENENTECH, INC. (US) 2023-06-01 — — WO disclosed
Send feedback